Di Federico A, Wang K, Chen MF, Barsouk AA, et al. First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAF(V600E)-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study. Lancet Oncol 2025;26:1357-1369.
PMID: 41038185